Erlotinib Versus Pemetrexed as Second-Line Therapy in Treating Patients With Advanced Lung Adenocarcinoma
Clinical trial NCT01565538 · COMPLETED
Trial details
- NCT number
- NCT01565538
- Sponsor
- Si-Yu Wang
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-12-01
- Primary completion
- 2012-05-01
- Enrollment
- 123
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.